跳至主要内容
临床试验/NCT02125669
NCT02125669已完成不适用

The Role of the 595 nm Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas at Low Risk Anatomical Sites: Outcome of a Double Blind Randomized Placebo Controlled Trial

Hautklinik Darmstadt0 个研究点目标入组 100 人开始时间: 2012年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
主要终点
complete response

研究概览

简要总结

Pulsed dye laser (PDL) treatments have been suggested to be a safe and effective therapeutic approach for treating basal cell carcinomas. Robust supporting evidence is, however, lacking due to inconsistent design of available studies. The purpose of this study is to evaluate the PDL's efficacy and safety in treating superficial basal cell carcinoma (sBCC) at low risk anatomical sites in an evidence based study setting.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • histologically confirmed unpigmented sBCC on the trunk and extremities
  • maximal tumour diameter 30 mm

排除标准

  • Fitzpatrick skin type >III
  • pregnancy
  • previous BCC treatment within 4 weeks
  • coagulation disorders
  • photo sensitizing medication
  • any indication of poor compliance

结局指标

主要结局

complete response

时间窗: 9 months

次要结局

  • patients satisfaction(9 months)
  • side effects(9 months)
  • reduction of tumor diameter and tumor thickness(9 months)

研究者

发起方
Hautklinik Darmstadt
申办方类型
Other
责任方
Principal Investigator
主要研究者

Maurizio Podda

PD Dr. med.

Hautklinik Darmstadt

相似试验